Table 2 Comparison of Preoperative Risk Factors for Postoperative Death Within 1 Year After Tumor Recurrence
Characteristics | Death Within 1 Year (23) | Death After 1 Year (83) | P value |
|---|---|---|---|
Age, years | |||
Average | 41.83 | 39.61 | 0.618 |
Range | 24–68 | 18–70 | |
Gender, n (%) | |||
Female | 5 (21.7%) | 27 (32.5%) | 0.233 |
Male | 18 (78.2%) | 56 (67.5%) | |
Location, n (%) | |||
Frontal | 8 (34.8%) | 30 (37.3%) | 0.953 |
Temporal | 4 (17.4%) | 17 (20.5%) | |
Multi | 6 (26.1%) | 22 (26.5%) | |
Other | 5 (21.7%) | 14 (15.7%) | |
Initial symptom, n (%) | |||
Epilepsy | 17 (73.9%) | 39 (47.0%) | 0.019 |
Other | 6 (26.1%) | 44 (53.0%) | |
First diagnosed grade, n (%) | |||
WHO II | 16 (69.6%) | 61 (73.5%) | 0.447 |
WHO III | 7 (30.4%) | 22 (26.5%) | |
First diagnosed pathology type, n (%) | |||
Astrocytoma | 16 (69.6%) | 46 (55.4%) | 0.164 |
Oligodendroglial | 7 (30.4%) | 37 (44.6%) | |
Malignant transform, n (%) | |||
Yes | 8 (34.8%) | 25 (30.1%) | 0.425 |
No | 15 (65.2%) | 58 (69.9%) | |
P53, n (%) | |||
Mutant | 19 (82.6%) | 58 (69.9%) | 0.172 |
Wide | 4 (17.4%) | 25 (30.1%) | |
1p/19q Codeletion, n (%) | |||
yes | 6 (26.1%) | 41 (49.4%) | 0.038 |
No | 17 (73.9%) | 42 (50.6%) | |
IDH1, n (%) | |||
Mutant | 15 (65.2%) | 58 (69.9%) | 0.425 |
Wide | 8 (34.8%) | 25 (30.1%) | |
ATRX, n (%) | |||
Mutant | 15 (65.2%) | 51 (61.4%) | 0.470 |
Wide | 8 (34.8%) | 32 (38.6%) | |
Ki-67, n | |||
Average | 16.13 | 17.95 | 0.870 |
Range | 2–80 | 0–70 | |
Adjuvant therapy, n (%) | |||
Stupp | 10 (43.5%) | 58 (69.9%) | 0.019 |
Other | 13 (56.5%) | 25 (30.1%) | |
NLR, n (%) | |||
≤1.815 | 4 (17.4%) | 32 (38.6%) | 0.046 |
>1.815 | 19 (82.6%) | 51 (61.4%) | |
PLR, n (%) | |||
≤100.749 | 4 (17.4%) | 36 (43.4%) | 0.018 |
>100.749 | 19 (82.6%) | 47 (56.6%) | |
LMR, n (%) | |||
≤3.029 | 6 (26.1%) | 27 (32.5%) | 0.375 |
>3.029 | 17 (73.9%) | 56 (67.5%) | |
RDW, n% (%) | |||
≤13.4 | 11 (47.8%) | 59 (71.1%) | 0.035 |
>13.4 | 12 (52.2%) | 24 (28.9%) | |
Fib, g/L, n (%) | |||
≤2.80 | 10 (43.5%) | 58 (69.9%) | 0.019 |
>2.80 | 13 (56.5%) | 25 (30.1%) | |
DD, mg/L, n (%) | |||
≤0.187 | 11 (47.8%) | 61 (73.5%) | 0.020 |
>0.187 | 12 (52.2%) | 22 (26.5%) | |
TTR, days | |||
Average | 1777.48 | 1814.64 | 0.908 |
Range | 216–5425 | 177–6310 | |